CD4 and AIDS: Many patients entered the cohort with advanced immunosuppression, characterized by CD4 + counts below 200 cells/mm3 (32.0%) and presence of AIDS-defining signs and symptoms (45.7%), although most had no record of hospitalization due to HIV in the year prior to entering the cohort (52.7%) (Table 1).